# Reprieve ADHF EFS IDE

> **NCT03866551** · NA · UNKNOWN · sponsor: **CardioRenal Systems, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DEVICE:** Reprieve Cardiovascular System

## Key facts

- **NCT ID:** NCT03866551
- **Lead sponsor:** CardioRenal Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866551, "Reprieve ADHF EFS IDE". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03866551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*